Boston Scientific Corp. (BSX) — Hedge Fund Ownership Q4 2025
BSX
- Boston Scientific Corp. (BSX) is held by 7 of 81 tracked hedge funds, with Egerton Capital (6%) and Maverick Capital (3%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- New position in BSX stock was initiated by Maverick Capital (3%).
- The biggest increases in BSX holdings came from Egerton Capital (+1%), highlighting conviction.
- The biggest decreases in BSX holdings came from Polen Capital Management (-28%) and Viking Global Investors (-5%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to Boston Scientific Corp. (BSX) by -12% vs the prior quarter and +15% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Egerton Capital John Armitage
|
5.58% | 5.4M | +1.37% | — | $513.5M | $95.35 | — |
| 2 |
Maverick Capital Lee Ainslie
|
3.02% | 2.9M | NEW | — | $280.7M | $95.35 | — |
| 3 |
Polen Capital Management
|
1.64% | 4.0M | -28.20% | — | $383.3M | $95.35 | — |
| 4 |
Viking Global Investors Andreas Halvorsen
|
0.64% | 2.5M | -4.99% | +15.54% | $239.3M | $95.35 | — |
| 5 |
Lone Pine Capital Stephen Mandel
|
0.14% | 202K | NEW | — | $19.2M | $95.35 | — |
| 6 |
Mairs & Power
|
0.01% | 10K | -1.27% | -1.31% | $970,282 | $95.35 | — |
| 7 |
Dodge & Cox
|
0.00% | 89K | — | -6.23% | $8.5M | $95.35 | — |
| 7 | Total | — | 15.2M | -12.00% | +14.56% | $1.45B | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.